Start Date
November 30, 2020
Primary Completion Date
August 31, 2022
Study Completion Date
November 30, 2022
Liraglutide Pen Injector [Victoza]
Increasing dose of Liraglutide: 0.6 mg/d for the first week, 1.2 mg/d for the second week aiming for a maximum of 1.8 mg/d beginning with the third week (or highest tolerated dose).Subcutaneous injection once daily via pre-filled pen
Placebo
Matching Placebo once daily, subcutaneous injection via pre-filled pen.
Department of Internal Medicine I, University Hospital, Aachen
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
RWTH Aachen University
OTHER